RWM
PDSB icon

Rialto Wealth Management’s PDS Biotechnology PDSB Stock Holding History

Rialto Wealth Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$671 Buy
+761
New +$808 ﹤0.01% 1527
2025
Q4 		– Sell
-400
Closed -$404 – 1775
2025
Q3 		$404 Hold
400
– – ﹤0.01% 1320
2025
Q2 		$532 Buy
+400
New +$543 ﹤0.01% 1122

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Rialto Wealth Management's PDSB Position: Q2 2026 in Review

Rialto Wealth Management opened a new position in PDS Biotechnology (PDSB) in Q2 2026: 761 shares worth $671. The stake represents ﹤0.01% of the portfolio and ranks #1527 among its holdings. This is a return to the name: Rialto Wealth Management previously reported a position in PDSB as recently as Q3 2025.

Rialto Wealth Management first reported a position in PDSB in Q2 2025 and has held it in 3 quarters since. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Rialto Wealth Management held 761 shares of PDS Biotechnology worth $671 as of Q2 2026.
  • PDS Biotechnology was a new Rialto Wealth Management position in Q2 2026.
  • PDS Biotechnology made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #1527 holding.
  • Rialto Wealth Management first reported a position in PDS Biotechnology in Q2 2025 and has held it in 3 quarters since.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.